Skip to main content
Log in

Inhibitory effect of sulfonylureas on protein phosphatase activity in rat pancreatic islets

  • ORIGINAL
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

We have measured protein phosphatase (PP) activity in crude homogenates as well as in the total 105,000×g supernatant and precipitate fractions from normal rat pancreatic islets. On the basis of the inhibition produced by either 1 nM or 1 µM okadaic acid, both PP1 and PP2A activity were present in crude islet homogenates in equivalent proportions (53% and 47%, respectively); PP1 was the main activity present in the precipitate, whereas in the supernatant it was PP2A. Tolbutamide, glybenclamide and glyclazide significantly decreased PP activity in islet homogenates in a dose-dependent manner, with a K i0.5 value that in the case of glybenclamide correlated with its K d for binding site, its EC50 on KATP channel, and its EC50 on insulin release. These data indicate that PPs play a role in the control of insulin secretion and suggest a further possible target for sulfonylureas within their overall action as insulin secretagogues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 19 September 1996 / Accepted in revised form: 20 December 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gagliardino, J., Rossi, J. & García, M. Inhibitory effect of sulfonylureas on protein phosphatase activity in rat pancreatic islets. Acta Diabetologica 34, 6–9 (1997). https://doi.org/10.1007/s005920050057

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005920050057

Navigation